Letter | Published:

Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-& gamma; signal transduction pathway

Naturevolume 366pages166170 (1993) | Download Citation

Subjects

Abstract

INTERFERONS (IFNs) & alpha;/& beta; (type I) and & gamma; (type II) bind to distinct cell surface receptors1, inducing transcription of overlapping sets of genes by intracellular pathways that have recently attracted much attention2,3. Previous studies using cell lines selected for their inability to respond to IFN-& alpha; (ref. 4) have shown that the protein kinase Tyk2 plays a central role in the IFN & alpha;/& beta; response5. Here we report the isolation of the cell line & gamma;l A, selected for its inability to express IFN-& gamma;-inducible cell-surface markers, that is deficient in all aspects of the IFN-& gamma; response tested, but responds normally to IFNs & alpha; and & beta;. The mutant cells can be complemented by the expression of another member of the JAK family of protein tyro-sine kinases, JAK2 (refs 6& ndash;9). Unlike IFNs & alpha; and & beta;, IFN-& gamma; induces rapid tyrosine phosphorylation of JAK2 in wild-type cells, and JAK2 immunoprecipitates from these cells show tyrosine kinase activity. These responses are absent in & gamma;l A cells. JAK2 is therefore required for the response to IFN-& gamma; but not to IFNs & alpha; and & beta;.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Pestka, S., Langer, T. A., Zoon, K. C. & Samuel, C. E. A. Rev. Biochem. 56, 727–777 (1987).

  2. 2

    Pellegrini, S. & Schindler, C. Trends biochem. Sci. 18, 338–342 (1993).

  3. 3

    Müller, M. et al. Nature 366, 129–135 (1993).

  4. 4

    Pellegrini, S., John, J., Shearer, M., Kerr, I. M. & Stark, G. R. Molec. cell. Biol. 9, 4605–4612 (1989).

  5. 5

    Velazquez, L., Fellous, M., Stark, G. R. & Pellegrini, S. Cell 70, 313–322 (1992).

  6. 6

    Wilks, A. F. et al. Molec. cell. Biol. 11, 2057–2065 (1991).

  7. 7

    Harpur, A. G., Andres, A-C., Ziemiecki, A., Aston, R. R. & Wilks, A. F. Oncogene 7, 1347–1353 (1992).

  8. 8

    Firmbach-Kraft, I., Byers, M., Shows, T., Dalla-Favera, R. & Krolewski, J. J. Oncogene 5, 1328–1336 (1990).

  9. 9

    Silvennoinen, O. et al. Proc. natn. Acad. Sci. U.S.A. 90, 8429–8433 (1993).

  10. 10

    Reid, L. E. et al. Proc. natn. Acad. Sci. U.S.A. 86, 840–844 (1989).

  11. 11

    Sewel, W. A., Brown, M. H., Dunne, J. & Owen, M. Proc. natn. Acad. Sci. U.S.A. 83, 8718–8722 (1986).

  12. 12

    Schindler, C., Shuai, K., Prezioso, V. R. & Darnell, J. E. Jr Science 257, 809–813 (1992).

  13. 13

    Shuai, K., Schindler, C., Prezioso, V. R. & Darnell, J. E. Jr Science 258, 1808–1812 (1992).

  14. 14

    Müller, M. et al. EMBO J. 12, 4221–4228 (1993).

  15. 15

    Decker, T., Lew, D. J., Mirkovitch, J. & Darnell, J. E. Jr EMBO J. 10, 927–932 (1991).

  16. 16

    Kanno, Y. et al. Molec. cell. Biol. 13, 3951–3963 (1993).

  17. 17

    Pearse, R. N., Feinman, R., Shuai, K., Darnell, J. E. Jr & Ravetch, J. V. Proc. natn. Acad. Sci. U.S.A. 90, 4314–4318 (1993).

  18. 18

    Khan, K. D. et al. Proc. natn. Acad. Sci. U.S.A. 90, 6806–6810 (1993).

  19. 19

    Perez, C., Wietzerbin, J. & Benech, P. D. Molec. cell. Biol. 13, 2182–2192 (1993).

  20. 20

    Witthuhn, B. A. et al. Cell 74, 227–236 (1993).

  21. 21

    Argetsinger, L. S. et al. Cell 74, 237–244 (1993).

  22. 22

    Stahl, N. & Yancopolous, G. D. Cell 74, 587–590 (1993).

  23. 23

    Larner, A. C. et al. Science 261, 1730–1733 (1993).

  24. 24

    Igarishi, K-I., David, M., Larner, A. C. & Finbloom, D. S. Molec. cell. Biol. 13, 3984–3989 (1993).

  25. 25

    Morgenstern, J. P. & Land, H. Nucleic Acids Res. 18, 1068 (1990).

  26. 26

    Farrar, M. A., Campbell, J. D. & Schrieber, R. D. Proc. natn. Acad. Sci. U.S.A. 89, 11706–11710 (1992).

  27. 27

    Cook, J. R., Jung, V., Schwartz, B., Wang, P. & Pestka, S. Proc. natn. Acad. Sci. U.S.A. 89, 11317–11321 (1992).

Download references

Author information

Author notes

  1. Olli Silvennoinen: Department of Pharmacology, New York University Medical Center, New York, New York 10016, USA

  2. Bruce A. Witthuhn, Frederick W. Quelle and James N. Ihle: Department of Biochemistry, St Jude Children's Research Hospital, 332 North Lauderdale, Memphis, Tennessee 38101-0318, USA

  3. Chris Schindler: Department of Molecular Medicine, Columbia University Medical Center, New York, New York 10032, USA

  4. George R. Stark: Department of Molecular Biology, Cleveland Clinic Foundation Research Institute, 9500 Euclid Avenue, Cleveland, Ohio 44195-5001. USA

Affiliations

  1. Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London, WC2A 3PX, UK

    • Diane Watling
    • , Dmitry Guschin
    • , Mathias Müller
    • , Olli Silvennoinen
    • , Bruce A. Witthuhn
    • , Frederick W. Quelle
    • , Neil C. Rogers
    • , Chris Schindler
    • , George R. Stark
    • , James N. Ihle
    •  & lan M. Kerr

Authors

  1. Search for Diane Watling in:

  2. Search for Dmitry Guschin in:

  3. Search for Mathias Müller in:

  4. Search for Olli Silvennoinen in:

  5. Search for Bruce A. Witthuhn in:

  6. Search for Frederick W. Quelle in:

  7. Search for Neil C. Rogers in:

  8. Search for Chris Schindler in:

  9. Search for George R. Stark in:

  10. Search for James N. Ihle in:

  11. Search for lan M. Kerr in:

About this article

Publication history

Received

Accepted

Issue Date

DOI

https://doi.org/10.1038/366166a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.